Free tool
Stocks listed on Nasdaq GM
We cover 45 companies listed on Nasdaq GM. The median market value in the group is $2.64B. Across the group, the median move over the past trading day is −0.53%. 69% of the 45 with a 200-day average trade above it. Price change over the past year runs from −58.0% to +277.7% across the middle 80 percent of the group, with a median of +36.6%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
45 of 701 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% | Nov 5, 2026 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% | Nov 3, 2026 |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% | Nov 5, 2026 |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% | Nov 11, 2026 |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% | Oct 29, 2026 |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% | Nov 2, 2026 |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% | Nov 5, 2026 |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% | Nov 4, 2026 |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% | Nov 5, 2026 |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% | Nov 9, 2026 |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% | Nov 4, 2026 |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% | Nov 5, 2026 |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% | Nov 5, 2026 |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% | Nov 3, 2026 |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% | Nov 5, 2026 |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% | Nov 4, 2026 |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% | Oct 29, 2026 |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% | Nov 5, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% | Nov 12, 2026 |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% | Nov 5, 2026 |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% | Nov 3, 2026 |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% | Nov 3, 2026 |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% | Nov 12, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% | Nov 5, 2026 |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% | Nov 12, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% | Nov 4, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% | Nov 3, 2026 |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% | Nov 5, 2026 |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% | Nov 11, 2026 |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% | Nov 9, 2026 |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% | Nov 5, 2026 |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% | Nov 4, 2026 |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% | Nov 4, 2026 |
| HYPR | Hyperfine, Inc. | $92.06M | Micro cap | −29.99% | Nov 12, 2026 |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% | Nov 16, 2026 |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% | Nov 12, 2026 |
| NNOX | Nano-X Imaging Ltd. | $68.83M | Micro cap | −77.77% | Sep 9, 2026 |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% | Sep 2, 2026 |
| BTMD | biote Corp. | $52.54M | Micro cap | −53.87% | Nov 4, 2026 |
| TVGN | Tevogen Inc. | $43.63M | Micro cap | −85.43% | Nov 13, 2026 |
| SNWV | SANUWAVE Health, Inc. | $41.89M | Micro cap | −89.02% | Nov 6, 2026 |
| TELA | TELA Bio, Inc. | $31.03M | Micro cap | −60.73% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.